Obesity Trial, Recruiting NCT07447440 Sponsor: Clinica Universidad de Navarra, Universidad de Navarra Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07447440
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Healthy Participants:

  • People who have been postmenopausal for at least one year
  • People who are a normal weight, overweight, or obese
  • People with no personal history of cancer
  • People whose weight has been stable (within 5%) over the last three months
  • People who are willing to sign a consent form and follow all study procedures

Breast Cancer Participants:

  • People who have been postmenopausal for at least one year
  • People who are a normal weight, overweight, or obese
  • People diagnosed with a specific type of breast cancer called "luminal subtype," at an early stage (stage I or II), where surgery to remove the tumour is planned and no treatment before surgery is needed
  • People who are willing to sign a consent form and follow all study procedures

Who may not be able to join:

Healthy Participants:

  • People with a personal history of cancer
  • People currently following any weight loss programme, including special diets, supplements, or weight loss surgery
  • People who have previously had bariatric (weight loss) surgery
  • People whose regular medication has not been stable for at least the last three months
  • People currently taking diabetes medication or hormone replacement therapy (HRT)
  • People with significant problems affecting the digestive system, such as active stomach ulcers, chronic inflammatory bowel conditions, or conditions that affect how the body absorbs food (confirm with trial site for full list)
  • People who drink more than 14 units of alcohol per week (for women) or more than 20 units per week (for men)
  • People who have had surgery that has caused lasting changes to their digestive system
  • People with liver disease, except for non-alcoholic fatty liver disease (a common form of fat build-up in the liver)
  • People with cognitive (thinking or memory) difficulties or a psychiatric condition
  • People who may have difficulty following the study procedures

Breast Cancer Participants:

  • People whose breast cancer is at a stage higher than stage II, or who have a type of breast cancer other than luminal subtype
  • People who need treatment before surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Miguel Burgos, PhD, Center for Nutrition Research

Phone: +34948425600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Registry
ClinicalTrials.gov
Start date
15 October 2025
Est. completion
30 November 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Lipid mediators profile

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov